Skip to content
TalkGuest talkBPSA

Why Psychedelic Harm Reduction?

Dr. med. Tomislav Majić

Photos

Tomislav Majić speaking into the microphone, behind him the slide “Why Psychedelic Harm Reduction: SUD?” with the cover of T. C. Boyle’s novel “Outside Looking In”View from the upper rows into the lecture hall, Tomislav Majić at the lectern, listeners spread across the rows
  • Tomislav Majić speaking into the microphone, behind him the slide “Why Psychedelic Harm Reduction: SUD?” with the cover of T. C. Boyle’s novel “Outside Looking In”
  • View from the upper rows into the lecture hall, Tomislav Majić at the lectern, listeners spread across the rows

Abstract

Harm reduction is an approach in more recent drug research and therapy that is concerned with the health and social consequences of using addictive substances rather than with the goal of abstinence. Since psychedelics, although they are counted among the psychoactive substances, are generally not associated with the development of dependence, the term “psychedelic harm reduction” may not seem immediately self-evident. All the more so since, in the eyes of many users, psychedelics are considered harmless and safe. This lecture will address the possible risks and complications of psychedelics. Following a brief historical overview, a classification of psychedelic-related complications will be proposed that is based on the temporal dynamics of the substances’ effects.

Live only, in person and on Zoom – there will be no recording this time.

About the speaker

Dr. med. Tomislav Majić

Psychiatrist and psychotherapist at the Psychiatric University Hospital of Charité at St. Hedwig Hospital in Berlin, and co-head of the Psychedelic Substances Research Group at Charité. He heads a department of general psychiatry, an outpatient clinic for dual diagnosis and the “Ambulanz Psychedelische Substanzen”, an outpatient clinic treating patients with psychedelic-related disorders. He is a researcher and study therapist in trials investigating psychedelic-assisted therapy, editor of the volume “Psychedelic Harm Reduction”, and a lecturer at the Berlin Institute for Psychotherapy and Psychoanalysis.

In cooperation with

Berlin Psychedelic Science Association Logo
Berlin Psychedelic Science Association

A joint lecture by the PSNG and the BPSA.

Further reading

  1. Ambulanz Psychedelische Substanzen at St. Hedwig Hospital – the outpatient clinic for problems after psychedelic use.
  2. Psychotropic Substances research group at Charité – research on psychedelics and psychedelic-assisted therapy.
When
Wednesday, 4 November 2026
19:00 – 20:30
Where
Zoom and in person at HU Berlin

In numbers

attendees
61
of which online
46